Aniruddha Sengupta

DGM, Partnerships and Portfolio Strategy @ Sun Pharma Advanced Research Company | Cancer Research PhD

Role: Dgm, Partnership and Portfolio Strategy at Sun Pharma Advanced Research Company Ltd.
Location: Delhi, IN
LinkedIn followers: 500 followers

General Business & ManagementView LinkedIn profile

About Aniruddha Sengupta

At SPARC, my role bridges science, strategy, and business. It includes Scientific Due…

Experience

Dgm, Partnership and Portfolio Strategy
Sun Pharma Advanced Research Company Ltd.
Jan 2021 — Present · Vadodara, IN

Skills

Immunoprecipitation
Molecular Biology
Confocal Microscopy
Cell Biology
Flow Cytometry
Cancer
Real-Time Polymerase Chain Reaction (Qpcr)
In Vivo
Fluorescence Microscopy
Protein Purification
Protein Chemistry
Signal Transduction
Biochemistry
Immunohistochemistry
Cell
Tissue Culture
Cancer Cell Biology
Western Blotting
Transfection
Qpcr
Cancer Research
Rt-Pcr
Reverse Transcription Polymerase Chain Reaction (Rt-Pcr)
Animal Models
Cell Culture
Tumor Biology
Protein Expression
Mouse Models
Molecular Cloning
In Vitro
Immunocytochemistry

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@sparc.life
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Sun Pharma Advanced Research Company Ltd.

Pharmaceutical Manufacturing · 699 employees · Vadodara, Gujarat, India

SPARC (NSE: SPARC; BSE: 532872) is a biopharmaceutical company continuously innovating new therapies in oncology, neurodegeneration, and immunology. SPARC's value proposition lies in our brick-and-mortar infrastructure to effectively translate therapies from the bench, through clinical studies, to regulatory approval. This engine has resulted in approval of two NDAs. Our approved products are marketed by our commercial partners in the US, China, and India. We are 400+ strong team spread across three global locations, with a vibrant research community of 350+ scientists working on a robust pipeline of clinical and preclinical programs. Our teams' strengths span the R&D spectrum: small and large molecule drug discovery; CMC development; preclinical translation (including NDA-enabling toxicology); and clinical development and operations. All of this makes SPARC unique among other small biopharma companies, especially single-asset or single-therapy focused companies. We continue to build and strengthen our innovation engine with emphases on strong scientific execution, high value analytics, and aggressive portfolio management, to redefine patient care in areas of unmet need.

sparc.life

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Aniruddha Sengupta

Experience

Dgm, Partnership and Portfolio Strategy

Skills

Find verified contacts for anyone on LinkedIn